Department of Pediatrics, Division of Pediatric Nephrology, Holtz Children’s Hospital, University of Miami Miller School of Medicine, Miami, USA
Department of Pediatrics, Division of Pediatric Nephrology, Holtz Children’s Hospital, University of Miami Miller School of Medicine, Miami, USA
Department of Pediatrics, Division of Pediatric Nephrology, Holtz Children’s Hospital, University of Miami Miller School of Medicine, Miami, USA
Department of Pediatrics, Division of Pediatric Nephrology, Holtz Children’s Hospital, University of Miami Miller School of Medicine, Miami, USA
Department of Pediatrics, Division of Pediatric Nephrology, Holtz Children’s Hospital, University of Miami Miller School of Medicine, Miami, USA
Department of Pediatrics, Division of Pediatric Nephrology, Holtz Children’s Hospital, University of Miami Miller School of Medicine, Miami, USA
Department of Pediatrics, Division of Pediatric Nephrology, Holtz Children’s Hospital, University of Miami Miller School of Medicine, Miami, USA
Copyright © 2014 Jayanthi Chandar, Wacharee Seeherunvong, Carolyn Abitbol, Chryso Katsoufis, Alcia Edwards-Richards, Teresa Cano, Gastón Zilleruelo et al. This is
an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any
medium, provided the original work is properly cited.
How to Cite this Article
Chandar, J. , Seeherunvong, W. , Abitbol, C. , Katsoufis, C. , Edwards-Richards, A. , Cano, T. and Zilleruelo, G. (2014) Endothelin-1 Antagonist in the Management of Refractory Systemic Hypertension in Children with End Stage Kidney Disease: A Case Series.
World Journal of Cardiovascular Diseases,
4, 217-224. doi:
10.4236/wjcd.2014.45029.